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S U M M A R Y  
The ability of mouse alloantibody to inhibit EA rosette formation and antibody- 
dependent cell-mediated cytotoxicity (ADCC) was used to study the expression of 
H-2K, Ia and H-2D antigens in various tissues. As previously reported antisera 
against each of these groups of antigens inhibited B lymphocyte EA rosette 
formation. Continuing studies confirmed these observations but established that 
quantitative differences may exist in the ease with which antibody against antigens 
in each region can inhibit EA rosettes: anti H-2D and anti-Ia seemed stronger 
relative to their cytotoxic titres than anti H-2K. Possible reasons for this are 
discussed. When rosette forming cells from other tissues were studied, (bone 
marrow cells, peritoneal macrophages and tumour cells), they were inhibited by 
anti H-2K and anti H-2D sera but not by anti Ia sera, presumably reflecting the 
restricted distribution of Ia antigens in those tissues. 
Inhibition of ADCC by various antisera reflected qualitatively and quantita- 
tively the expression of H-2 antigens in various tissues : whereas effector cell activity 
in spleen, bone marrow, or peritoneal cell populations was inhibited by anti H-2 or 
anti-Ia sera, the amount of inhibition observed with anti-Ia was much less when 
the tissue expressed little Ia antigen (bone marrow) than when it expressed abun- 
dant Ia antigen (spleen). The ability of cytotoxicity inhibition to detect antibody 
coated cells was used to assess the relative amount of Ia antigen on thymus and on 
lymph node cells, showing significant amounts of Ia antigen on thymus cells. Fc 
receptor inhibition studies may thus be useful as new approaches to the study of 
the expression of the antigens of the major histocompatibility complex. 
I N T R O D U C T I O N  
Fc receptors and their relationships with membrane alloantigens are natural sources of 
interest to the immunogeneticist. The ability of antibody against a wide variety of cell 
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surface antigens to inhibit Fc receptor binding (and particularly the ability of anti-Ia to 
inhibit binding of aggregated immunoglobulin by the Fc receptor (Dickler & Sachs, 1974)) 
has greatly stimulated studies in this field. In addition to providing information about 
possible antigenic associations of the Fc receptor? such studies can provide methodology to 
study properties of the cell surface antigens themselves. The present report will show that 
Fc receptor dependent assays can be used to obtain information about the expression of 
cell surface antigens in various tissues. 
We have been studying the inhibitory action of antibody in each of two Fc receptor 
dependent assays: (i) EA rosettes, in which Fc receptor bearing cells (usually B lympho- 
cytes) form rosettes with antibody-coated erythrocytes; (ii) antibody-dependent cell- 
mediated cytotoxicity (ADCC), in which cytotoxic effector cells bearing Fc receptors lyse 
antibody-coated Wr-labelled target cells. In EA rosettes, antibody against antigens on the 
surface of the rosette forming cell (RFC-in our previous studies usually B lymphocytes) 
inhibited EA rosette formation (Schirrmacher et al., 1975a; Halloran et al., 1975). Anti- 
bodies against H-2 antigens (in the K, I and D regions), a non H-2 antigen (Ly 4.2), mouse 
immunoglobulin (MIg), and mouse B lymphocyte antigen (MBLA) were inhibitory. 
Although the precise mechanism of inhibition was obscure, the strong inhibition produced 
by the F(ab'), portions of the antibodies showed that the Fc portions of the antibody were 
not involved. Steric hindrance of cell contact was a possible explanation of the inhibition 
(for discussion see Halloran et al., 1975; Schirrmacher & Halloran, 1975). 
In ADCC, antibody against any cell surface antigens in the incubation mixture can form 
antibody-cell complexes which compete with the antibody-coated target cell for the Fc 
receptors of the cytotoxic effector cell, producing competitive inhibition of cytotoxicity 
(Halloran & Festenstein, 1974; Halloran et al., 1974; Schirrmacher et al., 1975b). Anti- 
bodies against a wide variety of surface components (H-2K, H-2D, Ia, non H-2, MTg, 
MBLA, brain associated theta (BA 0)) have all produced specific inhibition. Interestingly? 
however, no antibody yet tested has inhibited the Fc receptors of cytotoxic effector cells by 
binding directly to antigens associated with the Fc receptor (i.e. the F(ab'), portions of 
these antibodies never produced inhibition) (Schirrmacher et al., 1975a and b). 
The present studies were undertaken to assess whether these Fc receptor inhibition systems 
would reflect the expression of cell surface antigens on cells other than spleen and lymph 
node cells. Since the H-2K and H-2D antigens would be present on all tissues, we first 
sought to establish more information about the K and D region antigens which were 
detected in EA rosette inhibition: were these the same antigens as are expressed on ery- 
throcytes, and could we assess quantitatively the potency of antibody to these antigens 
compared with antibody against Ia antigens in EA rosette inhibition ? Having established 
these points, we sought to assess the expression of H-2K, Ia and H-2D region antigens on 
various tissues by inhbition of EA rosettes and ADCC. Finally, we assessed the relative 
amounts of Ia antigen on thymus and lymph node cells quantitatively by cytotoxicity 
inhibition, to illustrate how the use of this technology could contribute to the understanding 
of a current immunogenetic problem. 
MATERIALS A N D  METHODS 
EagIe's minimal essential medium (The Wellcome Trust Research Laboratories, Kent, 
England) with 0.02 M Hepes (Wellcome), gentamycin (5 pglml), and 5 % fetal calf serum 
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(Flow Laboratories, Inc., Rockville, Maryland, U.S.A.) was used. Rosette assays were 
done in 63.5 x 9.5 mm round bottomed polystyrene tubes (LP/3 tubes, Luckham Limited, 
Burgess Hill, Sussex, England). Cytotoxicity assays were done in 44 mm x 9 mm poly- 
styrene tubes (The Metal Box Co., Surrey, England). Radioactive sodium chromate ("Cr) 
was obtained from the Radiochemical Centre, Amersham, England. 
C57Bl/lO.ScSn (BlO), BlO.A, BlO.D2/n, BlO.BR, BlO.A(SR) BALB/c, CBA/H, and 
DBA/2 mice were bred in the London Hospital Medical College from breeding pairs 
obtained from the Laboratory Animal Centre, Carshalton, Surrey, England. Antisera were 
prepared by repeated weekly intraperitoneal injection of spleen cells. With antiserum (B10. 
x B1O.A)FI anti B10.D2 and B10.D2 anti BlO.A, absorption with red cells, (from which 
the leucocytes had been removed by centrifugation), was performed, and the absorbed 
antibody was re-eluted by acid treatment as described elsewhere (Staines, et al. 1975). 
This procedure eliminated any Ia antibody from the serum. 
The activity of these antibodies was determined in a Y r  release assay as described by 
Sanderson (1 965) and Wigzell (1965), and in a complement-dependent microcytotoxicity 
assay under phase contrast microscopy (Halloran et a]., 1974). Serum A.TH anti A.TL was 
prepared and tested as previously described (David el al., 1973). Details of the specificity 
of the antisera employed are found in Table 1. 
TAE~LE 1. Specificity of anti H-2 sera used 
Designation Description H-2 and Ia activities * 
H-2K 
Anti H-2K.23 A.TL anti A.AL 23, 8, 11 
Anti H-2K.23 eluate t B10.D2 anti B1O.A 23, 1, 5, 11 
others 
Anti H-2K.31 Q (B x A)Fl anti B10.D2 31 
Anti H-2K.31 eluate t (B x A)F1 anti B10.D2 31 
Anti H-2K.33 5 (B10.D2 x A)Fl anti BlO.A(5R) 33, others 
Anti H-2K.8 0 8, 9, 3, 7 
Anti H-2KD.1 Q 
C3H.OH 1 
Anti H-2D.4 Q$ (BIO.AKM x 129)Fl anti B1O.A - 
BlO.A(SR) - 
(B10 x A.SW)FI anti BIO.M 
(C3H.SW x HTG)Fl anti 
Anti H-2D.4, 13 
Anti H-2D.13 Q (B10 x LP.RIII)FI anti BlO.A(SR) - 
Anti Ia 1, 2, 3, 7, 15 
Anti Ia 1, 2, 3 
(B10 x C3H.OL)Fl anti 
A.TH anti A.TL 





- 1, 32 
4 - 
- 4, 13, 42 others 
15 4, 13, 42 others 
- 1, 2, 3, 7, 15 
1, 2, 3 - 
~ 
* For H-2 chart see Demant et al. 1973; for Ia specificities 1-10 see Shreffler & David 1975; Ia 11 to 16, 
David, unpublished data. Activity against S region gene products is a theoretical possibility in many of these 
antisera, as is activity against G region products (David et al., 1975; Klein et al., 1975). 
t Prepared by absorption to appropriate mouse erythrocytes, and subsequent acid elution from the ery- 
throcytes, thus removing anti Ia activity. 
$ Ia 6 could be present in this antiserum but is not demonstrable. (P. Halloran unpublished; M. Hess, 
personal communication). 
0 These antisera were obtained from the Transplantation Immunology Branch, N.I.A.I.D., NIH, Bethesda, 
Maryland. Details of the raising and testing of these sera are contained in NIH catalogue and its 1973 and 
1974 supplements (Snell, 1968). 
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Details of the production of rabbit anti chicken erythrocyte serum and the preparation of 
its IgG fraction have been described previously (Halloran et al., 1974). Rabbit anti-ox 
erythrocyte serum was a gift of Dr A. Munro, Department of Pathology, Cambridge, 
England. 
Mouse thymocyte suspensions were prepared by teasing thymus tissue, from which 
parathymic lymph nodes had been dissected, through a fine stainless steel mesh. Spleen and 
lymph node cell suspensions were prepared in a similar way. Bone marrow cells were 
prepared by irrigating the femoral marrow cavities with heparinized medium. Peritoneal 
cells were prepared by irrigation of the peritoneal cavities with 5 ml of medium, When 
‘activated’ peritoneal cells were to be tested, the animals were injected intraperitoneally 48 
hr previously with 4 ml of fetal bovine serum. 
Details of the preparation of EA rosettes and their inhibition by anti H-2 antisera are 
published elsewhere (Halloran et al., 1975). In brief, the suspension of mouse cells (3-6 x 
106/ml) to be assessed was first preincubated with normal mouse serum or antiserum, for 30 
mjn at room temperature; the cells were washed once, and centrifuged at 4°C with a 2% 
suspension of chicken erythrocytes coated with rabbit anti-chicken erythrocyte gamma 
globulin. The cells were resuspended, and the percentage rosette-forming cells was counted 
in a Neubauer chamber. At least 600 mouse cells were usually examined for rosettes. 
Details of the cytotoxicity inhibition assay (CIA) methodology have been published 
elsewhere (Halloran et al., 1974). In brief, the usual cytotoxicity system consisted of mouse 
spleen, bone marrow, or peritoneal cells (cytotoxic effector cells), ”Cr-labelled chicken 
erythrocytes (CRBC), and minute amounts of rabbit antiserum against chicken erythro- 
cytes (RACA). The antiserum to be tested was added either directly, or was first pre- 
incubated with another population of mouse cells and these washed ‘antibody-cell com- 
plexes’ were added. In these experiments either a 4 hr protocol (using 2 x lo6 spleen cells, 
lo4 CRBC and 1/50,000 RACA) or an 18 hr protocol (lo6 spleen cells, 2 x lo4 CRBC, and 
1/100,000 RACA) was used. Incubations were done at 37°C in a 5% COz, 10% O2 atmos- 
phere. At the end of the incubation period, the tubes were centrifuged; aliquots were 
removed and counted in a Packard Autogamma well-type scintillation counter and the 
percent W r  release was determined. All samples were done in triplicate and the means 
and standard deviations were determined. 
RESULTS 
Quantitative comparisons of antibody against K, l o r  D region antigens in EA rosette inhibition 
Our previous observations that anti H-2 sera specifically inhibited EA rosette formation 
raised several questions: (i) were antibodies against K, I and D region antigens all active in 
this inhibition? (ii) if so, did the antibodies against K and D region antigens recognise the 
H-2K and D serologically detectable antigens as expressed on red cells? (iii) are there 
quantitative differences between the efficiency of antibodies against K, I or D region anti- 
gens in producing rosette inhibition? 
The first question has already been examined in detail (Halloran et al., 1975) and we here 
add the observation that ‘anti H-2K.23’ serum (A.TL anti A.AL) inhibits rosette formation 
(Fig. 1, Table 2). Thus antibodies against K, I or D region antigens clearly can inhibit 
rosette formation. But are the K and D region antigens the same as those on red cells? To 
resolve this we tested antisera absorbed to red cells and subsequently re-eluted to remove 
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FIG. 1. Comparison of the titration curves of various antisera in EA rosette inhibition (con- 
tinuous lines) with a typical complement-dependent lysis titration curve from an anti H-2 
serum (broken line). The antisera shown are anti Ia, 1, 2, 3, (01, anti H-2K.23 eluate (o), 
anti H-2D.4 (a), and anti H-2K.23 (0). The 50% rosette inhibition titre was determined from 
such curves by extrapolation. The complement dependent lysis titre was the mean of two 
experiments in which highest dilution producing detectable lysis was determined. 
TABLE 2. Comparison of various anti H-2 sera for strength in complement dependent 
cytotoxicity and EA rosette inhibition 
Ratio of EA 
rosette 
Strain EA rosette t inhibition titre 
Antiserum tested CDL titre * inhibition titre to CDL titre 
AntiIa 1,2,3,7,15 
Anti Ia.1, 2, 3 
Anti H-2D.4 
Anti H-2D.4; 13 
Anti H-2KD.l 
Anti H-2K.23 
Anti H-2K.23 eluate 

































* Highest dilution giving detectable lysis, using guinea pig complement. 
t Determined by extrapolation from where the serial dilution curve crossed the 50% 
inhibition line plotted as shown in Fig. 1 .  
anti-Ia antibody. These experiments, shown in Table 2 and Fig. 1, demonstrate that these 
eluates continued to show specific activity in rosette inhibition. Thus the H-2K antigens 
(and presumably the H-2D antigens as well) seem to be the same as those found on red 
cells, and therefore probably represent the usual serologically detectable H-2K antigens. 
But quantitative differences in the inhibitory potency of anti H-2K, anti H-2D and anti- 
Ia antibody might still exist. To investigate this we compared the strength of the rosette 
inhibitory activity with the strength of the cytotoxic activity in various antisera. We deter- 
mined the titre producing 50% inhibition of EA rosette formation (because of its relative 
objectivity) and compared this with the highest titre producing detectable cytotoxicity in 
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CDL. Typical titration curves obtained in both assays are shown in Fig. 1. There was an 
obvious difference between the curves produced with the two techniques: the more gentle 
uniform curve produced in rosette inhibition, v .  the steeper curve of cytotoxicity, may have 
implications for our understanding of the mechanisms involved. When the 50 % inhibition 
titre was determined from curves like these and divided by the maximal CDL titre, the 
quotient reflected the amount of inhibitory activity per unit of cytotoxic activity present, as 
shown in Table 2. The anti-Ia and anti H-2D sera were considerably stronger than the anti 
H-2K serum and the eluates. Possible explanations for and implications of these obser- 
vations will be discussed. 
The expression of K, I and D region antigens on Fc receptor bearing cells derived from varioiis 
tissues 
(a) EA rosette inhibition studies. We previously established that RFC’s were inhibited 
by antisera against a wide variety of antigens expressed on their surfaces. This characteristic 
provided a potential system for studying the cell surface antigens expressed on various 
types of RFC, such as bone marrow cells, peritoneal macrophages, and tumour cells. As 
shown in Table 3, bone marrow RFC’s were strongly inhibited by antibody against their 
K and D region antigens but not by antibody against I region antigens or MIg, agreeing with 
previous observations using bone marrow cells (Halloran et al., 1975). Table 3 also illus- 
trates that ox red cells (ORBC) coated with rabbit anti-ox antibody can be substituted for 
chicken red cells (CRBC) as EA. Experiments with ox erythrocytes as EA tested in parallel 
with the usual CRBC EA have shown remarkably similar results in EA rosette inhibition 
(P. Halloran, unpublished observations) and ORBC have been substituted for CRBC in 
some experiments. 
TABLE 3. Inhibition of EA-RFC * from different tissues: bone marrow cells 
BALB/c CBA/H 
Antiserum % EA-RFC % Inhibition % EA-RFC % Inhibition 
- 34.5 2 1.4 30-7 0.5 
Anti H-2D.4 1:20 5.7k3.9 84(+)t 32.3+ 1.5 0(-) 
Anti H-2KD.1 1 :20 34.0 + 2.7 1 (-) 7.4 5 2.0 76 (+) 
Anti Ia 1, 2, 3, 7, 15 1 :20 35.7 2 3.0 0 (+) 27.5 +la0 12 (+) 
R anti-MIg 1 :20 33*2+ 2.5 4 (+) N D  
* Indicator cells: Ox red blood cells (OREC) coated with rabbit anti-ORBC. 
t (+) or (-) indicates the reaction predicted on the basis of CDL testing of lymph node 
cells from these strains with these sera. 
Table 4 shows the results of similar studies testing normal and ‘activated’ peritoneal 
cells, which are composed chiefly of macrophages. Antisera against K and D antigens 
produced marked inhibition of the EA-RFC whereas anti-Ia produced comparatively little 
inhibition. It should be noted, however, that with activated macrophages the inhibition 
with anti H-2K and H-2D was considerably less than observed with other types of Fc 
receptor bearing cell types. This confirmed previous observations that activated macro- 
phages were relatively resistant to inhibition by anti H-2 sera. (Kerbel, 1975, submitted for 
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TABLE 4. Inhibition of EA-RFC from different tissues: peritoneal cells 





Antiserum BALB/c t BIO.A(5R) B10.D2 A.TH cells$ 
Anti H-2D.4, 13 76 (+I D 81 (+> 67 (+> 67 (+> 28 (+> 
Anti H-2K.31 NDll ND 78 (+) -2 (-1 25 (+> 
Anti H-2K.33, Ia.9 ND 80 (+> 1 (-1 -1 (+I 9 (-1 
Anti Ia 1, 2, 3, 7 14 25 (+I -1 (+I -5 (-1 -8 (+> 
Rabbit anti MIg 12 (+I ND 19 (+I ND 13 
* See footnote 1, Table 3. 
t The percentage of peritoneal cells which formed EA rosettes after treatment with normal serum (control) 
2 Peritoneal cells induced by intraperitoneal injection of fetal bovine serum 48 hr before harvesting. 
$ See footnote 2, Table 3. 
7 ND =not done. 
was: BALB/c 40%; BIO.A(SR): 75 %; B10.D2: 75%; A.TH: 57%, ‘activated‘ B10.D2 = 68.2 
publication). The fact that a small and variable amount of inhibition of peritoneal RFCs 
was often seen after pretreatment with anti-Ia and anti-MIg sera presumably reflected the 
presence of some Ia positive and MTg positive peritoneal cells, respectively. 
EA rosette formation by P815Y mastocytoma tumour cells was strongly inhibited by 
anti H-2 sera, as shown in Table 5. Thus anti H-2KY or anti H-2D sera strongly inhibited 
EA rosette formation but anti-Ia had no effect. 
In summary, antisera against H-2K and H-2D antigens produced marked inhibition of 
EA rosette formation of spleen, lymph node, bone marrow, peritoneal macrophage, and 
tumour cells ; only ‘activated’ macrophages were fairly resistant to such inhibition. Anti-Ia, 
in contrast, strongly inhibited spleen and lymph node EA RFC‘s (which are presumably Ia  
positive B lymphocytes), but had Iittle or no effect on bone marrow cells and peritoneal cells 
(which are largely Ia negative (McDevitt e l  al., 1974; Hammerling et al., 1975), and P815Y 
TABLE 5. Inhibition of EA-RFC from different tissues: 
P815Y * 
~~ ~~~~~ ~ ~~ ~~ 
Pretreatment % EA-RFC % Inhibition 
NMS 320 k 2.0 
Anti H-2D.4 7.0 k 2.5 78 (+It 
Anti H-2K.8 6.7 -t 2.3 79 (+> 
Anti H-2D.13 3.7 f 1.7 88 (+> 
Anti-Ia 33.0 & 1-6 0 (+I 
* P815Y mastocytoma tumour cells were maintained 
by serial peritoneal passage in DBA/2 mice but were 
removed prior to testing and cultured for 96 hr in Falcon 
flasks to remove adherent cells. 
t See footnote 2, Table 3. 
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turnour cells [which are Ia negative (Halloran et al., 1975)l. Anti MIg reacted in a fashion 
similar to anti Ia against bone marrow and peritoneal cells. These results supported the 
hypothesis that the inhibition of EA rosettes by antibody against a particular antigen 
seemed to reflect the ability of the antibodies to bind to surface antigens of the rosette 
forming cell, and did not imply a unique relationship of the antigens with the Fc receptor 
itself. Such results support the use of rosette inhibition to study the surface antigen expres- 
sion on RFC. 
(b) Cyrotoxiciry inhibition studies. Our published studies on the inhibition of antibody- 
dependent cellular cytotoxicity (ADCC) by alloantibody showed that the antibody bound 
to cells in the incubation mixture resulting in antibody-cell complexes, which competed with 
the antibody-coated target cell for available Fc receptors on cytotoxic effector cells, in- 
hibiting cytotoxicity. Anti H-2D, anti H-2K or anti-Ia sera could mediate this inhibition, 
presumably because all of these antigens were represented in the spleen cell population used 
as effector cells. It was therefore of interest to test other types of tissue as sources of effector 
cells, such as bone marrow or peritoneal cell preparations, since the composition of these 
cell populations is strikingly different from that of spleen cells. Preliminary experiments 
established the cell numbers required from each source to give equivalent degrees of 
cytotoxicity at 18 hr :lo6 spleen cells, 2.5 x lo5 bone marrow cells, and 2-5 x lo5 peritoneal 
cells. We compared the inhibition of cytotoxicity by various anti H-2 antisera using spleen, 
bone marrow and peritoneum as the source of the cytotoxic effector cells. 
The results (Table 6)  show that anti H-2K, H-2D and Ia gave strong and specific inhi- 
bition of cytotoxicity whether the effector cells were spleen cells, bone marrow cells, or 
peritoneal cells. The inhibition of each of these effector cell populations by anti-Ia sera 
presumably reflects the presence of at least some Ia positive cells in each of these tissues, 
since as few as 5 %  antigen positive cells have been shown to be detected in cytotoxicity 
TABLE 6. Inhibition of ADCC mediated by cells from different tissuk origin 
% Inhibition of antibody dependent cytotoxicity using 
Inhibitory antiserum CDL testing different effector cells * 
Spleen cells Peritoneal cells Bone marrow cells 
B10.D2 B10 B10.D2 B10 B10.D2 B10 B10.D2 B10 
+ 8 98 0 59 0 61 Anti H-2K.33 - 
Anti H-2K.8 + 53 8 48 10 37 0 
Anti-la 1, 2, 3, 7, 15 + + 91 81 37 7 40 19 
R anti-MIg + + 100 100 34 68 59 49 
- 
* Target cells: 2 x lo* 51Cr-labelled CRBC; anti-target cell antibody (RACA) 1 :50 OOO; effector cells: 
lo6 spleen cells or 2.5 x lo5 bone marrow cells or 2.5 x lo5 peritoneal cells; inhibitory antibody 1 :2OO; 
incubation time: 18 hr; the specific Wr-release in absence of inhibitory antibody varied with the different 
effector cells between 20% and 37%. The specificity control for anti Ia 1, 2, 3, 7, 15 (A.TH spleen cells) 
showed no inhibition of cytotoxicity. 
t The relative weakness of the reaction of this serum with B10 macrophages and bone marrow cells 
presumably reflects the presence of only one specificity (Ia, 3) reacting with B10 cells, compared with two 
(Ia, 7, 15) reacting with B10.D2 cells. Other factors (differences in representation of different Ia specificities 
in each tissue) might also be operative. 
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inhibition (Halloran et al., 1974). But since the number of Ia antigen bearing cells in each of 
these tissues varies, particularly between spleen (40-55 %) and bone marrow (5-15 %) 
(McDevitt et al., 1974), we should be able to demonstrate differences between these tissues 
in the degree of inhibition by anti-Ia. To study this possibility, equal numbers of spleen 
and bone marrow cells were tested in the presence of anti-Ia, anti H-2D, or normal mouse 
serum. Since this represents an excess of effector cell activity for the bone marrow cells the 
magnitude of inhibition was reduced, but the relative inhibition by anti-Ia compared to 
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FIG. 2. Comparison of cytotoxicity inhibition by antisera anti H-2D.4 (0) and anti-Ia 1, 2, 3, 
7,15 (0) using spleen and bone marrow effector cells. Although the magnitude of the inhibition 
of the bone marrow cells was less than that of spleen (note different scale) the altered order of 
the potency of the antisera is clearly shown. The 18 hr ADCC protocol was used (see methods). 
relative to the anti H-2D was much higher for the spleen cells, which have many Ia positive 
cells, than for bone marrow cells. Thus the cytotoxicity inhibition results reflected both the 
qualitative and quantitative antigen representation in a particular effector cell population. 
Furthermore, the relative amount of antigen in any cell population (whether or not 
effector cells were present) could be assessed by simply adding those cells, after pre- 
incubation with the appropriate antiserum, as third party ('inhibitor') cells. We applied this 
technique to the question of the amount of Ia on thymocytes relative to the amount of Ia on 
lymph node lymphocytes. As shown in Fig. 3 thymocytes or lymphocytes after pre-incu- 
bation in NMS or in anti H-2D or anti-Ia serum were added to the standard cytotoxicity 
system. The degree of inhibition observed showed that while Ia was greatly reduced on 
thymocytes compared to lymphocytes, it was still definitely expressed on them, confirming 
previous findings (David et al., 1973; Frelinger et al., 1974) about the presence of Ia on 
thymocytes. 
DISCUSSION 
The mapping of the H-2 antigens capable of mediating the inhibition of EA rosettes by 
antibody has been previously reported, (Halloran et al., 1975) and is further documented 
398 P. Halloran et al. 
Normal serum Anti I a  Anti H-2D 
50 r I I 
LN Thymus LN Thymus LN Thymus 
FIG. 3. Quantitative comparison of Ia antigen expression on thymus and lymph node cells. 
Thymocytes or lymph node cells (107/ml) were incubated at room temperature in anti-Ia, 1,2, 
3,7,15 (1/50) or anti H-ZD.4,13 (1/50) for 30 min. The cells were then washed twice and added 
to the standard 18 hr cytotoxicity protocol (see methods) a t  either 5 x 10S/tube (hatched bars) 
or 1-25 x 1OS/tube (solid bars). 
* 
here. Thus anti H-2K, anti-Ia, and anti H-2D have all been shown to inhibit, and in the case 
of H-2K the antigens responsible seem to be identical to those on erythrocytes, i.e. the 
conventional H-2K specificities. But the quantitative differences between various antisera in 
the degree of inhibition observed remains unexplained and could have important impli- 
cations. Antisera raised against H-2D antigens (with no Ia activity) and antisera raised 
against Ia antigens (with no H-2K or H-2D activity) seemed stronger than antisera against 
H-2K antigens (with no Ia activity). The relatively small number of sera tested in each 
group, and the unavailability of anti H-2D purified by the red cell absorption-elution 
process makes it difficult to draw definitive conclusions from these data, but certain possi- 
bilities can be entertained. The relative strength of the anti H-2D serum compared to the 
anti H-2K serum, for example, could be due to antibody against serologically undetectable 
gene products in the S or G regions. Evidence from other lines of investigation support the 
possibility of unsuspected activities in antisera against D end specificities (Arnaiz-Villeiia 
et al., 1975). The difference between anti H-2K and anti-Ia, however, is more difficult to 
explain. Perhaps differences in the uniformity of distribution of H-2K antigens compared to 
Ia antigens in the ceII membrane could account for such differences (Schultz et a/., 1975).* 
Can we reconcile our data with those of Dickler & Sachs (1974), which show convincingly 
that anti-Ia sera inhibit the binding of aggregated immunoglobulin to the B lymphocyte Fc 
receptor but anti H-2K and H-2D do not? Several possibilities are beginning to emerge: 
* The possibility that all of the inhibitory activity in anti H-2K and anti H-2D sera is due to undiscovered 
Ia specificities can be discounted for reasons presented elsewhere (Halloran et a/., 1975). Unsuspected 
activities against various regions may account for a portion of the quantitative strength of any of these 
antisera because the quantitative studies were not performed in recombinant mice. Indeed, the possibility of 
previously unrecognizable antibody specificities being detected in rosette inhibition is an intriguing subject 
for future exploration. 
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one possibility is that the differences between anti-Ia and anti H-2K or D is merely quanti- 
tative, but is seen more dramatically in the aggregate binding assay. The quantitative 
differences between H-2K and Ia in our assay could support this view. A second possibility 
is that two mechanisms are operating in the inhibition of B lymphocyte EA rosettes: a 
‘non-specific’ one which any antibody against cell surface antigens can mediate; and a 
‘specific’ interaction between Ia antigens and Fc receptors. If so, perhaps only the specific 
mechanism can produce aggregate binding inhibition. Even if anti H-2K and anti H-2D 
have no ability to block aggregate binding at all, a non H-2 antigen is now reported by 
Dickler & Sachs as inhibiting aggregate binding (Dickler, 1975) implying that Fc receptor 
inhibition is not unique to anti-Ia but is shared by other antibodies. Furthermore, recent 
studies have shown that the Fc receptor can be capped independently of Ia antigen (Pernis, 
1975 personal communication; Unanue, 1975) indicating that no covalent linkage between 
Ia antigens and Fc receptors is possible. In spite of the fact that the mechanism of the 
inhibition of aggregate binding by antibody is still unresolved, this assay seems to be more 
selective for anti-Ia than is the rosette inhibition assay. It may, therefore, prove very useful 
as an operationally specific assay for antibody against Ia antigens in human and other 
species. 
The inhibition of EA rosettes of bone marrow cells, macrophages, and tumour cells by 
anti H-2 sera can be predicted on the basis of the known tissue distribution of H-2K, H-2D 
and Ia antigens. Clearly, the Fc receptors on these cells are independent of Ia antigens. The 
observation, first made by Kerbel (1975), that ‘activated’ macrophages are inhibited much 
less than normal macrophages by anti H-2 sera, was explained by him as being due to a 
decrease in the amount of H-2 antigen on the surface of activated cells. An alternative 
explanation is found in the studies of Rhodes (1975) who documents that the Fc receptors of 
activated macrophages have a greatly increased activity for immunoglobulin. 
The CIA provides a quantitative and C’ independent method of studying antigens on 
cells, without relying on cell destruction as an end point. The demonstration that bone 
marrow cells and peritoneal cells behaved similarly to spleen cells in the cytotoxicity 
inhibition system shows that the property of binding adjacent antibody-cell complexes, 
and thereby becoming inhibited, is not unique to spleen cytotoxic effector cells, but may be a 
property of all such cells. The experiment with thymocytes is one of several, all of which 
(with different Ia specificities) produced similar results indicating a significant amount of Ia 
antigen in thymus, a finding supported by some investigators (David et al., 1973; Hauptfeld 
et al., 1973; Gotze et al., 1973; Frelinger et al., 1974; Lonai & McDevitt, 1974) who find 
Ia on T cells or thymocytes, but disputed by others (Sachs & Cone, 1973; Hammerling 
et al., 1974). While not wishing to discuss this controversial issue at length, it would seem 
from studies of the percentage of EA-RFC in thymus (< 1.0%) that lymph node cell 
contamination of thymus preparations could not explain the observed degree of inhibition, 
since the amount of B lymphocyte contamination required to account for the inhibition by 
anti-Ia would produce at least five times as many EA rosettes as we actually observed. 
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